Site Map
Posts Why some multiple sclerosis- patients stop disease modifying treatment in MS and why some don’t start at all What’s New In Parkinson’s Rating Scales? Welcome Message From The Co-Chairs Of The International Scientific And Organising Committee Weight Lifting Improves Physical Function in Parkinson’s Weighing Botox’s Migraine Benefits Against Costs WCNR2022: Experts discuss new findings on how to help the nervous system in the reorganisation process after irreversible damage Voice Disturbance Analysis Detects Parkinson’s Vitamin D Levels Correspond to Disability in MS Visual stress: origins and treatment Vesalio launches pVasc Thrombectomy System in the U.S. for peripheral occlusions Uncontrolled Hypertension Could Bring Increased Risk For Alzheimer’s Disease Treatment Options For Atypical Parkin-Sonisms Treating Brain Tumors With Bacteria Gets Neuro-surgeons Banned Trauma-Induced Epilepsy May Be Prevented By Cooling The Brain Following Injury Transcranial Neuro-stimulation Reduced Postop Pain, Opioid Use Topical Pain Relievers: FDA Issues Burn Warning Time To First Relapse As An Endpoint In Multiple Sclerosis Clinical Trials The Role Of Apomorphine In The Effective Management Of Parkinson’S Disease – Highlights From Cony 2014 The Clinical Validation Of Objective Measurement Of Movement In Parkinson’s Disease The Angels (Acute-Networks StrivinG For ExceLlence In Stroke) Initiative: Solving A Problem By Giving Physicians The Tools They Need To Create A Solution THC Fails to Delay Progression of Multiple Sclerosis Tenecteplase Edges TPA in Acute Stroke Technical Advances In Neurosurgery Tai Chi Improved Postural Stability in Parkinson’s Disease Symptom Triad May Identify Parkinson’s Risk Surgical Removal of Brain Thrombus Boosts Recovery Study Suggests New Potential Alzheimer’s Treatment Strategy Study Hints at Statins’ Protective Effect Against Parkinson’s Study Finds Many Missed MS Diagnoses in Emergency Department Study Finds Long-Term Benefits Of DBS In Refractory Epilepsy Studies Identify Early Changes In Familial Alzheimer’s Disease Strokes Mix Up Brain And Muscle Coordination Stroke Treatment From Onset To Rehabilitation Stroke Severity Is Key in Hospital Rankings for Stroke Outcomes Stroke Prevention in AF: Study Finds Some Differences Among New OACs Stroke care taking flight with the wings of ANGELS Stroke Association Reviewing Stroke Definition, New Anticoagulants Spinal Cord Stimulation an Option for Chronic Pain Some Recommendations To Address The Burden Of Stroke In Europe Solitaire Trumped Merci in Stroke Clot Retrieval Trial Solitaire Clot Remover Effective for Large Artery Stroke Skin Cancer Drug Steps Into New Alzheimer’s Study Significant Risk Factors In The Etiology Of Arterial Ischemic Stroke In Children Selecting patients for endovascular therapy and recent developments and clinical experience with Medtronic devices Secondary Headaches Flag Medical Conditions in Pregnancy Scores Help Identify Stroke Patients at Risk of Brain Bleed Rotigotine Patch Has Favorable Results in Parkinson’s, Restless Legs Role of Patent Foramen Ovale Varies in Cryptogenic Strokes Robots May Extend Post-Stroke Race Risk Factors Identified for Impulse Control Disorders in Parkinson’s Rare Brainstem Glioma Doesn’t Stop Former Marine Psychosis in Alzheimer’s May Recur After Dropping Risperidone Primary Care Docs Unsure When To Refer For Pediatric Epilepsy Surgery Pretreatment ASPECTS Reading Affects Stroke Outcomes Pregnancy, Contraception Data Highlighted in Epilepsy Registry Prediction Rule Targets Side Effects of Antiepileptic Drugs Plotting A Better Pathway For Parkinson’s Disease: The My PD Journey Project Pilot Program Shows Cardiac Rehab Can Help Poststroke Physiotherapy Found to Have Short-Term Benefit in Parkinson’s PET/CT Pinpoints Physiological Evidence Of Chemo Brain PET Radiotracer Identifies Glioma Treatment Response Past & Future Of Stroke Care In Europe Parkinson’s Life – A new ‘Webzine’ For The International Parkinson’s Community Now Live! Panel Votes Against Hydrocodone Because Of Abuse Potential Pain Scales: What to Ponder When Making Your Pick Overview Of Treatment In Infantile Spasms Oral Relaxin Improves Poststroke Recovery Optogenetic Manipulation Of The Cholinergic System: Potential Implications For The Treatment Of Memory Deficits In Alzheimer’s Disease Onset Periods of Depression Linked to Different Dementias Olfaction in migraine and its psychiatric comorbidities: a narrative review Ocular Tremor a Possible Biomarker for Early Parkinson’s Disease Occipital Nerve Block For Cluster Headache: Two Thumbs Up Novel Stroke Prophylaxis Strategies: When Should Device-Based Cardiac Occlusion Therapies Be Considered? Nondrug Interventions Can Improve Dementia Patients’ Lives Nocturnal Sleep Boosts Working Memory Training in Parkinson’s NHS England releases new resources on intercultural dementia care including a joint guide with Alzheimer Europe New Seizure Classifications Challenge Old Ideologies New MS Criteria Aim to Simplify Diagnosis New Drugs, Devices Edge Toward Clinical Use : New antiepileptic drugs in the pipeline may provide enhanced safety, tolerability, or potency. NeVa CLEAR Study results presented at ESMINT: innovative thrombectomy device achieves notable first-pass success and patient outcomes Neuropsychological Data Endorse Preclinical Alzheimer’s Neuromelanin MR Imaging In Parkinson’s Disease Nearly Half Have No Seizures at 10 Years Postop Natural Toxins: Their Roles In Developing PD National Plan Aims to Eliminate Alzheimer’s By 2025 Multiple Sclerosis Does Not Hurt Pregnancy, Birth Outcomes Monitoring Antipsychotic Side Effects Infrequent Among Dementia Patients Minimizing The Risk Of Hemorrhagic Stroke During Oral Anticoagulant Therapy For Atrial Fibrillation: The Neurologist’s Perspective Miniature Neuro-Stimulator Zaps Chronic Cluster Headache Migraine With Aura: Aspirin Called Best Prophylaxis Metformin Eyed for Lumbar Radiculopathy Pain Meta-Analysis: Statins Don’t Prevent Stroke, Death in Women Mental Training For Reinstallation Of Motor Programs After Stroke – Fiction Or Science? Mechanical Thrombectomy, The Change Is Coming. Mechanical Embolectomy Device Cleared for Acute Stroke Treatment MCI in Parkinson’s Linked to Frontostriatal Dysfunction Maternal Hypertension Ups Infant’s Stroke Risk Leaving A Legacy Of Stroke In Europe: A Community Of Dedicated Professionals Is Changing The Face Of Stroke In Europe Laquinimod Halted MS Disability But Not Relapses Is there A Multiple Sclerosis Epidemic And Is It The Result Of A Plethora Of Etiological Factors Or Of An As Yet Unknown Or Emergent Latent Risk Factor? IOM Report on Epilepsy Supports Comprehensive Approach Interferon-Beta Fails to Slow the Progression of Disability in MS Innovations Driven By Clinical Evidence Initiate Interferon Beta-1a Early to Delay Progression to MS Infection Correlated With Stroke Risk in Children In the Pipeline: Immunotherapy Slows Childhood Gliomas Implanted EEG Device Predicts Seizures in Early Study IL-7 Level May Mark Interferon Responsiveness Ideas and Innovations in Acute Ischaemic Stroke Treatment How Does Multiple Sclerosis Progress? Possible Clues Discovered Hormonal Contraception Raises Thrombotic Stroke, MI Risk High-Tech Stroke Recovery Aids? More Likely Than You May Think High-Risk Alzheimer’s Gene Increases Risk Of Other Dementias Help Make Real Change Happen For People Living With Dementia – Sign The Glasgow Declaration! Greater Costs, Morbidity Among Uncontrolled Epilepsy Patients Glutamate From Gliomas Sparks Seizures Genome Sequencing Set to Hunt for Alzheimer’s Clues Future MS Care: A consensus Statement Of The MS In The 21st Century Steering Group Frovatriptan Shown Advantageous In Menstrual Migraine Framingham Score Flags MI Risk After Stroke Fingolimod Label Advises ECG Monitoring at First Dose Filgrastim Fails to Improve Ischemic Stroke Outcomes FEBSTAT Study Hints At Predictors Of Epilepsy FDA Approves Oral MS Drug Teriflunomide Family History Tops Parkinson’s Disease Risk Factors Exercise May Be The Best Medicine For Alzheimer’s Exercise Improved Some Cognitive Function in Parkinson’s European Multiple Sclerosis Platform November 2014 Newsletter European Multiple Sclerosis Platform January 2015 Newsletter Epilepsy Raises Risk For Sudden Cardiac Arrest Epilepsy Incidence High Following Pediatric Stroke Epilepsy Incidence High Following Pediatric Stroke Environment Modifies ApoE e4-Related Risk of Alzheimer’s Disease EMSP’s MS Nurse Pro: Recognizing The Key Role Of MS Nurses Elderly Stroke Patients Have High Atrial Fibrillation Prevalence Effect of vibrotactile stimulation with cueing on falls in Parkinson’s disease: case study Early Surgery Yields Survival Benefit For Low-Grade Gliomas Early Surgery Deemed Best for Drug-Resistant Epilepsy Early Surgery Deemed Best for Drug-Resistant Epilepsy Dysfunctional Brain Areas May Fuel Inattention in Absence Epilepsy Drugs Found To Both Prevent And Treat Alzheimer’s Disease In Mice Drug For Alzheimer’s, Parkinson’s And MS Shows Promise Drug Dosage, Gender Affect Impulsivity Prognosis in Parkinson’s Disparities Seen in Care of Parkinson’s Patients : Better clinical care associated with neurologists was often unavailable to women or minorities. Depressed Stroke Survivors At Increased Risk Of Death Delirium Hits Hard in Hospitalized Alzheimer’s Patients CT Perfusion in Acute Stroke Questioned Continuing Donepezil Appears Best for Some Alzheimer’s Patients Coming Up Next: Managing Motor Complications In Parkinson’s Disease CombiRx For MS Not Better Than Monotherapy Coffee Consumption Linked to Lower Dementia Risk in Elderly CNS Events Not Immediately Fatal in Mantle Cell Lymphomas Clinical, Social Barriers Cripple Adequate Alzheimer’s Care Chronic Musculo-Skeletal Pain Travels With Chronic Daily Headache Chronic Migraine Linked to More Stressful Life Events Chemotherapy-Induced Neuropathy Linked to Falls Changing the paradigm for treating motor fluctuations in Parkinson’s: advancements in COMT inhibition Changing How We Prescribe Antipsychotics for Dementia Cerebrospinal Fluid Prognostic Biomarkers In Multiple Sclerosis Cavernous Malformation Of Left Basal Ganglia Region In A 12-Year-Old Boy – Case Report. Can Lapatinib Prevent Brain Metastases From Breast Cancer? Data ‘Inconclusive’ Buphenyl Identified As A Possible Drug For Alzheimer’s Disease Brain Tumors Glow ‘Like Lava’ With New Surgical Probe Botulinum Neurotoxin And Dystonia: A Case For Greater Flexibility In Treatment Regimens? Botox May Greatly Reduce Migraine Chronicity Botox For Chronic Migraine Brings Cost Savings Blood Test May Predict Alzheimer’s in Cognitively Impaired Biomarkers May Aid Differential Diagnosis of Dementias, Parkinsonism BG-12 Cuts Relapse Rate, Lesions in Multiple Sclerosis Benefit of IVIG in Alzheimer’s Disease Appears Durable Balloon Angioplasty Improves Venous Flow in MS Patients Atrial Fibrailation In Young Stroke Patients Antibody Reduces Amyloid-Beta in Alzheimer’s An insight into the upcoming ESMINT Annual Meeting – Nice, France 2022 Amyloid Imaging Agent May Aid Alzheimer’s Diagnosis Alzheimer’s Imaging Agent Considered For Medicare Coverage Alzheimer’s Drug Misses Primary End Points in Trials All Acute Antimigraine Drugs Protect Against Chronic Migraine Algorithm May Help Cut PML Risk With Natalizumab Air Pollution May Hurt Cognition, Increase Strokes Ahead Of The Journals: Discontinuing Risperidone In AD Advanced Imaging To Extend The Therapeutic Time Window Of Acute Ischemic Stroke Acetyl-l-Carnitine Yields Mixed Results for Chemo-Induced Neuropathy A very warm welcome to our new advisory board member – Wolfgang Reith A Second Amyloid Could Play A Role In Alzheimer’s Disease A Collaborative Initiative To Improve MS Research And Policy Across Europe 33rd Alzheimer Europe Conference agenda available online and new bursaries also available for early stage researchers! 2014 Joint Actrims-Ectrims Meeting – EMSP Highlights Report ‘Scrambler’ Device Reduces Refractory Neuropathic Pain ‘Drip and Ship’ Proves Safe for Stroke Zolpidem Linked To Higher Inpatient Fall Rates We are pleased to announce our most recent media partnership with ESMINT Watch for Heavy Smoking in Schizophrenia Using SSRIS In Pregnancy Tobacco, Drug Use High Early in Course of Schizophrenia Titrate ADHD Meds Quickly for Best Outcome The Papez circuit in schizophrenia 1: Neuropathological changes Suicidality Tied to ‘Self-Disorders’ in Early Schizophrenia Substance Abuse ‘Under-appreciated’ Among Elderly Psychiatric Inpatients Study Identifies Predictors Of Cognitive Impairment In Schizophrenia SSRI Antidepressants Safe For Depressed Epilepsy Patients Sleep-Disordered Breathing in Early Childhood Linked With Behavioral Outcomes Skimping on Sleep May Increase Stroke Risk School Staff Can Aid Treatment of Psychotic Children Schizophrenia With Panic Disorder May Be a Distinct Subtype Range of Childhood Trauma Linked to Schizophrenia Risk Raloxifene Gains Ground as Adjunctive Schizophrenia Treatment RAISE: Early Intervention In Schizophrenia Put To The Test Phyto-Anxiolytic Effects Of A Fixed Herbal Drug Combination For The Relief Of Stress And Its Potential To Reduce Benzodiazepine Use Phone Therapy for Depression Boosts Treatment Adherence Persistent Daytime Sleepiness Common Despite Effective CPAP Patients At Risk For Psychosis Show Gradual Decrease In Hippocampal Volume Pathological changes in the Salience Network in schizophrenia. Panel Votes Against Hydrocodone Because Of Abuse Potential Oppositional Defiant Disorder Linked to Symptoms of Schizophrenia Spectrum Disorder Onset Periods of Depression Linked to Different Dementias Olfaction in migraine and its psychiatric comorbidities: a narrative review Older Adults With Schizophrenia Can Achieve Remission OCD Commonly Precedes Schizophrenia in Men With Both Obstructive sleep apnea, oxidative stress and endotelial dysfunction Obesity Could Be Treated With Deep Brain Stimulation Obesity and diabetes linked to cognitive decline Novel Antipsychotic Treats Acute Mania in Bipolar Disorder More Evidence Confirms Relevance of Risk Allele to Schizophrenia Metformin Resolves Amenorrhea in Antipsychotic-Treated Schizophrenia Melatonin May Normalize Night Owl Sleep Schedules Medical Comorbidity Affects Disease Course in Bipolar Disorder Marijuana Use Linked To Better Adherence In Psychosis Marijuana Use Linked To Better Adherence In Psychosis Mania With Depressive Symptoms: A Pathophysio-Logical Review Liquid, Extended-Release Drug Approved For ADHD Lifetime Estrogen Exposure Linked to Depression Risk in Perimenopause Levomilnacipran SR Effective for Major Depressive Disorder Is My Child ‘Bipolar’? Intranasal Oxytocin May Ease Schizophrenia Symptoms Intervention For Epilepsy Patients Helped Prevent Depression Insomnia, Hypersomnia Disorders Criteria Proposed for DSM-5 Insomnia Drug Helps Patients Sleep Sooner, Longer ICD Shocks Boost Anxiety And Mortality Home Sleep Apnea Testing: Wake Up Call for Sleep Docs Hoarding Not Related To OCD, New Findings Reveal Findings Boost Causal Argument for Smoking, Depression FDA Approves Low-Dose Zolpidem for Night Awakening FDA Approves First Generic Form of Escitalopram Family-Focused Therapy May Help Resistant Pediatric OCD Exercise Rivals Sertraline in Comorbid CHD, Depression ESRS Sleep Medicine Textbook DSM-5 Cleared For Takeoff Don’t Overreach For Subthreshold Pediatric Bipolar Disorder Depression, Obesity Linked in Older Women but Not Older Men Depression May Shorten Survival in Kidney Cancer Depression Linked to Unhealthy Dieting Among Women Depression Can Be Migraine’s Tipping Point Depot Injection Boosts Antipsychotic Compliance in Schizophrenia CPAP Improves Mood in Sleep Apnea Patients Contemporary Perspectives On Lacanian Theories Of Psychosis Computer Training Leads to Lasting Improvements in Schizophrenia Combination Therapy Yields Mixed Results for PTSD, Substance Abuse Cognitive Therapy Plus Active Monitoring Benefits People at Risk of Psychosis C9orf72-Associated Frontotemporal Dementia And Psychosis Attention Retraining Enhances CBT For Adolescent Anxiety Adjunctive Lithium Reduces Use of Newer Antipsychotics in Bipolar A very warm welcome to our new advisory board member – Krassen Nedeltchev ‘On-Off’ Switches Shed Light on Brain Disorders : Narcolepsy, cataplexy, and REM sleep behavior disorder linked to errant ‘flip-flop’ mechanisms. ‘Mind-Pops’ More Common in Schizophrenia World-Renowned Doctor Heads Neurosurgery Clinic At GEMC World Parkinson’s Day: New strategies and hope for the future – Improving quality of life for patients with Parkinson’s disease – Prof. Bas Bloem, Prof. Claudia Trenkwalder & Prof. Angelo Antonini What is the future for NOACs in secondary prevention of ESUS? – Christina Sjöstrand, Hans-Christoph Diener & George Ntaios What Is My Pd Journey? Using The Apomorphine Sublingual Film In Practice: A Conversation Between Two Experts – Prof. Stuart Isaacson & Dr Eric Freire Treating motor fluctuations in Parkinson‘s Disease – Prof. Tobias Warnecke Transforming stroke care continuum together. A symposium supported and organised by Medtronic, ESO-WSO Virtual Congress 2020 Three Part Round Table Discussion: Which Techniques To Achieve FPE? Experts Share Their Daily Practice Protected: The Novel Oral Anticoagulants For Af…What Do The Sub-Analyses Tell Us? The Impact Of Thrombectomy For Stroke Patients In the UK – World Stroke Day 29th October 2022 The impact of COVID-19 for families with Parkinson’s Disease The efficacy of Apomorphine – A non-motor perspective: Prof. K Ray Chaudhuri The Diagnosis of Parkinson’s Disease – Dr. Francesca Morgante The Angels Initiative: Stroke care taking flight with the wings of Angels – ESO-WSO Virtual Congress 2020 Tailoring Levodopa according to patient characteristics Studies Bolster Alzheimer’s Amyloid Hypothesis Sleep Problems May Increase Risk for Dementia Roundtable discussion, Professors Werner Poewe, Angelo Antonini and Oliver Rascol discuss: “Is Delaying Levodopa a Disservice to Patients?” Roundtable Discussion – Brain, Heart and Kidneys: Preserving the Balance in Stroke Prevention Role, Function and Effect of Catechol-O-Methyl Transferase In Humans And Parkinson Disease Roche AD Taxi: Biomarkers for the diagnosis of late-stage dementia: Are we there yet? – Dr Diana Kerwin Roche AD Taxi: Biomarkers and the AD continuum – Prof. Henrik Zetterberg Roche AD Taxi: An introduction to biomarkers in AD – Prof. Henrik Zetterberg Rehabilitation In MS Reflections on Parkinson’s Disease Podcast – S2 EP4: ABC of PD – The Letter G: GBA and Genetics Reflections on Parkinson’s Disease Podcast – S2 EP7: ABC of PD – The Letter N (Part 2): Non Motor Symptoms – Apomorphine Reflections on Parkinson’s Disease Podcast – S2 EP6: ABC of PD – The Letter N: Non Motor Symptoms Reflections on Parkinson’s Disease Podcast – S2 EP5: ABC of PD – The Letter O: ON/OFF, On Demand Therapies, Opicapone REDEFINING FLOW DIVERSION WITH PIPELINE™ FLEX WITH SHIELD™ TECHNOLOGY: RELEASE OF NEW CLINICAL DATA Recognition and Management of Wearing Off Utilisation of Catechol-O-Methyltransferase (COMT) Inhibitors – Olivier Rascol RE-SPECT ESUS: Optimizing Prevention of Embolic Stroke of Undetermined Source – Mike Sharma, Richard A. Bernstein & Hans-Christoph Diener RE-SPECT ESUS: Dabigatran versus acetylsalicylic acid for stroke prevention in patients with embolic stroke of undetermined source – Hans-Christoph Diener Progesterone Quells Some Intractable Catamenial Seizures Prof. Dr. István Szikora – Press conference in October on the national stroke imaging network Prof. David Devos, MD, PhD Expert opinion on early start of infusion therapies in PD (interview during MDS Congress, Nice, France, 24.09.2019) People over the world talk about their Parkinson’s – Chapter 1 Patients’ testimonials, Stroke Management in Tunisia Past And Future Of Stroke Care In Europe – How Can Sits Support? Parkinson’s Life podcast: a voice for the global Parkinson’s community. LISTEN TO THE NEW EPISODE 5 Parkinson’s Disease: An update on basic concepts – Dr Monica Kurtis Parkinson’s Disease – Patient Roleplay Parenting And MS Panel Discusses Direction of Alzheimer’s Disease Research Oruen Testimonial by Professor Werner Poewe Nonmotor Symptoms In Parkinson’s Disease Recognition & Management New Developments In Parkinson’s Disease Management: Interviews With The Experts New Developments In Parkinson’s Disease Management: Interviews With The Experts Multidisciplinary care in PD – Does it make a difference? MS-Optic Neuritis MS-Exercise MS & Recreation Ms & Nutrition MS & Nutrition Ms & Exercise Ms & Education – Optic Neuritis MS & Depression MS & Dating Modulation of Levodopa Metabolism, The Role of COMT Inhibition and Opicapone ▼ Pharmacologic Profile Minimizing The Risk Of Haemorrhagic Stroke During Oral Anticoagulant Therapy For Atrial Fibrillation: The Neurologists’ Perspectives MicroVention-Terumo symposiums from ESMINT 2022, Nice, France Memory Declines Years Before Stroke Strikes Meet The Expert Session: A case-based debate: which of your patients might benefit from left atrial appendage occlusion? Medtronic ESMINT TV Industry Slots – Featuring: Dr Leonardo Renieri, Dr Aiden Hegarty, Dr Alejandro Tomasello, Prof. Jens Fiehler & Dr Saleh Lamin Medtronic ESMINT TV Industry Slot: INSPIRE – S: Dr Pasquale Mordasini & Dr Marc Ribo Medtronic – ESMINT 2021: Speaker: Professor René Chapot – Double Stent Retrievers (German) Medtronic – ESMINT 2021: Speaker: Professor René Chapot – Double Stent Retrievers (English) Medical Food, Supplement Appear Helpful for Dementias Measurement And Improvement Of Stroke Care, Eso-East Managing Bladder & Bowel Issues In MS Management of Parkinson’s Disease: From Science to Clinical Wisdom, Prof. Werner Poewe, Prof. Fabrizio Stocchi, Prof. Georg Ebersbach & Dr. Francesca Morgante Learnings from the ESUS trials – Jesse Dawson, Martin Grond & Maurizio Paciaroni Introduction To The Symposium Interview With WSO President: Prof. Michael Brainin Interview With MDS President: Prof. Claudia Trenkwalder Interview with EMSP President: Prof. Pedro Carrascal In-Hospital Management Of Acute Ischaemic Stroke: How Can We Do Better? Implementation of Best Practice in Europe: The Angels Initiative – The Role Of ESO Gamma Knife Surgery Cuts Seizures in Tumor Patients Gamma Knife Surgery Cuts Seizures in Tumor Patients Protected: From Studies To Real-Life Evidence…Latest Insights From The Garfield Af Registry Federal Funds Launch First Alzheimer’s Prevention Study Experimental Drug Improves Cognition, Memory in Alzheimer’s Exclusive Interview With ESO President: Prof. Martin Dichgans ESOC TV 2023 – Industry Slot: Astra Zeneca – Managing Bleeds in the Anticoagulated Patient; protocol and pathways ESOC 2023 TV – Industry Slot: Siemens – Advanced Imaging Techniques for Stroke Assessment and Prevention ESOC 2023 TV – Industry Slot: Neurologica Corp Samsung – The Benefits and Challenges of Setting Up a Mobile Stroke Program ESOC 2023 TV – Industry Slot: MicroVention – SOFIA™ Catheter 10th anniversary celebration – ETIS registry : ERIC™ Stent Retriever & SOFIA™ Catheter clinical data ESOC 2023 TV – Industry Slot: Apoplex – Rapid AF detection by automated continuous ECG monitoring using Stroke-Risk-Analysis (SRA®) ESOC 2017 Conference News ESOC 2017 – Day 2 Highlights ESOC 2017 – Day 1 Highlights ESO Endorsed Medtronic Webinar: AF screening in Cryptogenic Stroke patients, from guidelines to daily practice – 26th January 2023 ESMINT TV Studios 2024 ESMINT TV 2024 – Industry Session: Stronger Together: What’s next with WallabyPhenox – Speakers: Jens Fiehler & Markus Holtmannspötter ESC 2014. In-Hospital Management Of Acute Ischaemic Stroke: How Can We Do Better? EPDA #UniteForParkinsons Embolic Stroke of Undetermined Source (ESUS) – Valeria Caso, Danilo Toni & Martin Grond Early vs Late Use Of Levodopa – Angelo Antonini Early use of Levodopa vs Levodopa-sparing strategies Duloxetine Eases Pain of Chemo-Induced Neuropathy Dr Don Frei shares insights about REDglide Difference & discusses ADAPT Technology with Joan Kristensen Diagnosis and Management of Wearing Off – Repositioning COMTi and Response Duration in Levodopa Optimisation Diagnosis and Management of Levodopa Response Fluctuations in Parkinson’s Disease Despite Potential Gains, Patients Balk at Epilepsy Surgery Delayed ON And Wearing OFF – Complications Cryptogenic Stroke Webinar – ESO-WSO Virtual Congress 2020 Critical Case Considerations Continuous Dopaminergic Stimulation – Dr. Stuart Isaacson Clot-Busters Safely Treated Wake-Up Stroke Patients Clinical Manifestations, Pathophysiology and Impact of Motor Fluctuations in Patients Clinical Data of Opicapone ▼ for the Management of Motor Fluctuations in PD Patients Celebrating 5 years commercialisation in Europe with Vesalio during ESMINT 2023! CarePartners And MS Bringing paediatric epilepsy care to adult treatment: insights on rescue medication from paediatric neurology experts featuring Prof. Alexis Arzimanoglou, Lieven Lagae & Rima Nabbout Brainomix Symposium – ESOC 2023 – Prof. Joan Montaner, Dr Kiruba Nagaratnam, Dr Manu Moreu & Dr Alex Szolics Boehringer Ingelheim: WSC 2018 – secondary stroke prevention: new evidence that demands a verdict Boehringer Ingelheim: ESOC 2019 – How NOAC selection and reversal can help protect our patients: Your questions answered Boehringer Ingelheim: Angels WSC 2018 – Improving Stroke Care Across The World: The Angels Initiative Boehringer Ingelheim: Angels ESOC 2019 – THE ANGELS INITIATIVE: 3 YEARS AND COUNTING Boehringer Ingelheim: Actilyse WSC 2018 – New Frontiers in Acute Ischaemic Stroke Reperfusion Boehringer Ingelheim ESOC 2018 – Stroke Prevention and Treatment: New Insights Into NOACS and Reversal Bayer: ESOC 2019 – Brain, Heart and Kidneys: Preserving the Balance in Stroke Prevention Anticoagulation for Cerebral Venous Thrombosis Protected: Anti-Coagulation With Novel Oac’s In Af, Practical Guidance And Interactive Session Angels: FAST Heroes: Results of cross-country implementation of a global school-based stroke education campaign – ESOC 2022 Studios Angels ESOC 2018 – Experience From Today For The Stroke Care Of The Future Anemia Triples Post-Stroke Mortality Risk An Introduction to the Pharmacokinetics of Levodopa – Prof. Fabrizio Stocchi An alternative treatment to prevent stroke in patients with Atrial Fibrillation: Left Atrial Appendage Occlusion-Latest evidence Am Impakt: Apomorphine For Morning Akinesia Trial – Results Alive or Dead? Secondary Stroke Prevention with NOACs in ESUS – Ken Butcher Adjuvant PCV Chemo Hikes Oligodendroglioma Survival A2A Receptor Antagonists: Potential adjuvant therapies for levodopa optimisation A testimonial from the ESO past president – Valeria Caso A message from the ESO President – Professor Valeria Caso 1-2-1 interviews on WEB Study – Dr. Szikora, Dr. Arthur, Prof. Pierot & Propriety X Surface Treatment for Flow Diverter -Dr. Dion “I am Cheryl”.. Quality Of Life Perspectives From A Patient With Cervical Dystonia “I am David”.. Quality Of Life Perspectives From A Patient With Cervical Dystonia ‘Wearing off’ to L-DOPA and its underlying mechanisms What Really Causes Epilepsy? What is Epilepsy? What is Epilepsy and How is it Treated? What does the new information on using epilepsy medication during pregnancy mean? Welcome Message From The Co-Chairs Of The International Scientific And Organising Committee Trauma-Induced Epilepsy May Be Prevented By Cooling The Brain Following Injury Study Finds Long-Term Benefits Of DBS In Refractory Epilepsy Sleep and Epilepsy (Wellness Institute Whiteboard Video Series) Progesterone Quells Some Intractable Catamenial Seizures Primary Care Docs Unsure When To Refer For Pediatric Epilepsy Surgery Pregnancy, Contraception Data Highlighted in Epilepsy Registry Prediction Rule Targets Side Effects of Antiepileptic Drugs Overview Of Treatment In Infantile Spasms New Seizure Classifications Challenge Old Ideologies New Drugs, Devices Edge Toward Clinical Use : New antiepileptic drugs in the pipeline may provide enhanced safety, tolerability, or potency. Network Analysis of Epilepsy: A Big Data Approach Nearly Half Have No Seizures at 10 Years Postop IOM Report on Epilepsy Supports Comprehensive Approach International League Against Epilepsy (ILAE) 15th European Epilepsy Congress (EEC), 7–11 September 2024, Rome, Italy International Epilepsy Day 10th February: ACT FAST, STOP SEIZURES, SAVE LIVES Implanted EEG Device Predicts Seizures in Early Study Greater Costs, Morbidity Among Uncontrolled Epilepsy Patients Glutamate From Gliomas Sparks Seizures Gamma Knife Surgery Cuts Seizures in Tumor Patients FEBSTAT Study Hints At Predictors Of Epilepsy Epilepsy research: MRI | NHS Epilepsy Raises Risk For Sudden Cardiac Arrest Epilepsy Incidence High Following Pediatric Stroke Epilepsy and Mental Health: What You Should Know Early Surgery Deemed Best for Drug-Resistant Epilepsy Dysfunctional Brain Areas May Fuel Inattention in Absence Epilepsy Bringing paediatric epilepsy care to adult treatment: insights on rescue medication from paediatric neurology experts featuring Prof. Alexis Arzimanoglou, Lieven Lagae & Rima Nabbout World Stroke Day 2024 – Stroke Management at the University Hospital Bonn, Germany World Parkinson’s Day: New strategies and hope for the future – Improving quality of life for patients with Parkinson’s disease – Prof. Bas Bloem, Prof. Claudia Trenkwalder & Prof. Angelo Antonini What is the future for NOACs in secondary prevention of ESUS? – Christina Sjöstrand, Hans-Christoph Diener & George Ntaios WallabyPhenox – World Stroke Day 2024 Using The Apomorphine Sublingual Film In Practice: A Conversation Between Two Experts – Prof. Stuart Isaacson & Dr Eric Freire Update about desvenlafaxine use in depression: Connecting evidence with real world patients Treating motor fluctuations in Parkinson‘s Disease – Prof. Tobias Warnecke Three Part Round Table Discussion: Which Techniques To Achieve FPE? Experts Share Their Daily Practice The role of on-demand medications in Parkinson’s Disease – Prof. Joaquim Ferreira, Prof. Angelo Antonini & Dr Susan Fox The Impact Of Thrombectomy For Stroke Patients In the UK – World Stroke Day 29th October 2022 The impact of COVID-19 on Hemorrhagic Procedures The impact of COVID-19 for families with Parkinson’s Disease The efficacy of Apomorphine – A non-motor perspective: Prof. K Ray Chaudhuri The Diagnosis of Parkinson’s Disease – Dr. Francesca Morgante Testimonial from Dr. Sanjeev Nayak – Consultant Neuroradiologist at University Hospitals of North Midlands NHS Trust Tailoring Levodopa according to patient characteristics Stryker ESMINT 2023 – Prof. Dr. Markus Möhlenbruch Roundtable discussion, Professors Werner Poewe, Angelo Antonini and Oliver Rascol discuss: “Is Delaying Levodopa a Disservice to Patients?” Roundtable Discussion – Brain, Heart and Kidneys: Preserving the Balance in Stroke Prevention Role, Function and Effect of Catechol-O-Methyl Transferase In Humans And Parkinson Disease Roche AD Taxi: How can we support primary care physicians with an AD diagnosis? – Dr Diana Kerwin Roche AD Taxi: Biomarkers for the diagnosis of late-stage dementia: Are we there yet? – Dr Diana Kerwin Roche AD Taxi: Biomarkers and the AD continuum – Prof. Henrik Zetterberg Roche AD Taxi: An introduction to biomarkers in AD – Prof. Henrik Zetterberg REDEFINING FLOW DIVERSION WITH PIPELINE™ FLEX WITH SHIELD™ TECHNOLOGY: RELEASE OF NEW CLINICAL DATA Recognition and Management of Wearing Off Utilisation of Catechol-O-Methyltransferase (COMT) Inhibitors – Olivier Rascol RE-SPECT ESUS: Optimizing Prevention of Embolic Stroke of Undetermined Source – Mike Sharma, Richard A. Bernstein & Hans-Christoph Diener RE-SPECT ESUS: Dabigatran versus acetylsalicylic acid for stroke prevention in patients with embolic stroke of undetermined source – Hans-Christoph Diener Prof. Dr. István Szikora – Press conference in October on the national stroke imaging network Prof. David Devos, MD, PhD Expert opinion on early start of infusion therapies in PD (interview during MDS Congress, Nice, France, 24.09.2019) Prof. Angelo Antonini, MD, PhD – MDS Congress Madrid 2022 pRESET Testimonial: Dr Sanjeev Nayak – WallabyPhenox Pharmacodynamics of levodopa in the pathophysiology of fluctuations in Parkinson’s disease – Prof. Fabrizio Stocchi Patients’ testimonials, Stroke Management in Tunisia Parkinson’s Disease: An update on basic concepts – Dr Monica Kurtis Parkinson’s Disease – Patient Roleplay Oruen Testimonial by Professor Werner Poewe Oruen Testimonial by Dr. Monica Kurtis Nonmotor Symptoms In Parkinson’s Disease Recognition & Management NOACs in Secondary Stroke Prevention – Robin Lemmens, Ales Tomek & Milan R. Voško Multidisciplinary care in PD – Does it make a difference? Modulation of Levodopa Metabolism, The Role of COMT Inhibition and Opicapone ▼ Pharmacologic Profile MicroVention-Terumo symposiums from ESMINT 2022, Nice, France Meet The Expert Session: A case-based debate: which of your patients might benefit from left atrial appendage occlusion? Medtronic ESMINT TV Industry Slots – Featuring: Dr Leonardo Renieri, Dr Aiden Hegarty, Dr Alejandro Tomasello, Prof. Jens Fiehler & Dr Saleh Lamin Medtronic ESMINT TV Industry Slot: INSPIRE – S: Dr Pasquale Mordasini & Dr Marc Ribo Medtronic – Webinar Session: AVM Treatment Medtronic – Webinar Session: Aneurysm Treatment – Flow Diversion Complex Cases Medtronic – The Importance of Thrombectomy Medtronic – ESMINT 2021: Speaker: Professor René Chapot – Double Stent Retrievers (German) Medtronic – ESMINT 2021: Speaker: Professor René Chapot – Double Stent Retrievers (English) Medtronic – Acute Ischemic Stroke Launch Symposium Management of Parkinson’s Disease: From Science to Clinical Wisdom, Prof. Werner Poewe, Prof. Fabrizio Stocchi, Prof. Georg Ebersbach & Dr. Francesca Morgante Levodopa Mythology – Dr Alberto Espay Learnings from the ESUS trials – Jesse Dawson, Martin Grond & Maurizio Paciaroni Latest update on SESAME, SOFIA EPI & ERIC for distal Involving PD patients in their treatment management: Expert discussion: Prof Bas Bloem & Dr Margherita Fabbri Interview with the President of the ESMINT 2022 Annual Meeting – Dr Mohamed Aggour International Epilepsy Day 10th February: ACT FAST, STOP SEIZURES, SAVE LIVES ESOC TV 2023 – Industry Slot: Astra Zeneca – Managing Bleeds in the Anticoagulated Patient; protocol and pathways ESOC 2023 TV – Industry Slot: Siemens – Advanced Imaging Techniques for Stroke Assessment and Prevention ESOC 2023 TV – Industry Slot: Neurologica Corp Samsung – The Benefits and Challenges of Setting Up a Mobile Stroke Program ESOC 2023 TV – Industry Slot: MicroVention – SOFIA™ Catheter 10th anniversary celebration – ETIS registry : ERIC™ Stent Retriever & SOFIA™ Catheter clinical data ESOC 2023 TV – Industry Slot: Apoplex – Rapid AF detection by automated continuous ECG monitoring using Stroke-Risk-Analysis (SRA®) ESOC 2019 – MEDTRONIC CARE CONTINUUM: Improving Patient Pathway ESO Endorsed Medtronic Webinar: Cryptogenic Stroke Patients Need Answers: AF Screening Strategies & Patient Stratification ESO Endorsed Medtronic Webinar: AF screening in Cryptogenic Stroke patients, from guidelines to daily practice – 26th January 2023 ESMINT TV Studios 2024 ESMINT TV 2024 – Industry Session: Stronger Together: What’s next with WallabyPhenox – Speakers: Jens Fiehler & Markus Holtmannspötter Empowering Women in INR: The WIN Group’s Latest Initiative Embolic Stroke of Undetermined Source (ESUS) – Valeria Caso, Danilo Toni & Martin Grond Early vs Late Use Of Levodopa – Angelo Antonini Early use of Levodopa vs Levodopa-sparing strategies Dr Don Frei shares insights about REDglide Difference & discusses ADAPT Technology with Joan Kristensen Diagnosis and Management of Wearing Off – Repositioning COMTi and Response Duration in Levodopa Optimisation Diagnosis and Management of Levodopa Response Fluctuations in Parkinson’s Disease Continuous Dopaminergic Stimulation – Dr. Stuart Isaacson Clinical Manifestations, Pathophysiology and Impact of Motor Fluctuations in Patients Clinical Data of Opicapone ▼ for the Management of Motor Fluctuations in PD Patients Charco Neurotech – CUE1: Prof. James Kilner Celebrating 5 years commercialisation in Europe with Vesalio during ESMINT 2023! Bringing paediatric epilepsy care to adult treatment: insights on rescue medication from paediatric neurology experts featuring Prof. Alexis Arzimanoglou, Lieven Lagae & Rima Nabbout Brainomix Symposium – ESOC 2023 – Prof. Joan Montaner, Dr Kiruba Nagaratnam, Dr Manu Moreu & Dr Alex Szolics Boehringer Ingelheim: WSC 2018 – secondary stroke prevention: new evidence that demands a verdict Boehringer Ingelheim: ESOC 2019 – How NOAC selection and reversal can help protect our patients: Your questions answered Boehringer Ingelheim: Angels WSC 2018 – Improving Stroke Care Across The World: The Angels Initiative Boehringer Ingelheim: Angels ESOC 2019 – THE ANGELS INITIATIVE: 3 YEARS AND COUNTING Boehringer Ingelheim: Actilyse WSC 2018 – New Frontiers in Acute Ischaemic Stroke Reperfusion Boehringer Ingelheim ESOC 2018 – Stroke Prevention and Treatment: New Insights Into NOACS and Reversal Bayer: ESOC 2019 – Brain, Heart and Kidneys: Preserving the Balance in Stroke Prevention Anticoagulant Reversal Strategies in ICH – Current challenges and latest insights Angels: FAST Heroes: Results of cross-country implementation of a global school-based stroke education campaign – ESOC 2022 Studios Angels ESOC 2018 – Experience From Today For The Stroke Care Of The Future An Introduction to the Pharmacokinetics of Levodopa – Prof. Fabrizio Stocchi An alternative treatment to prevent stroke in patients with Atrial Fibrillation: Left Atrial Appendage Occlusion-Latest evidence Alzheimer Europe 2020 Conference Round table discussion: Maintaining dementia as a European priority Alive or Dead? Secondary Stroke Prevention with NOACs in ESUS – Ken Butcher A2A Receptor Antagonists: Potential adjuvant therapies for levodopa optimisation A testimonial from the ESO past president – Valeria Caso 1-2-1 interviews on WEB Study – Dr. Szikora, Dr. Arthur, Prof. Pierot & Propriety X Surface Treatment for Flow Diverter -Dr. Dion ‘Wearing off’ to L-DOPA and its underlying mechanisms What Parkinson’s Feels Like: artist with Parkinson’s releases new illustrated book We are pleased to announce our most recent media partnership with ESMINT VIEW LATEST ISSUE: Oruen – The CNS Journal (Vol. 5, Issue 2 – Dec 2019) Vesalio launches pVasc Thrombectomy System in the U.S. for peripheral occlusions VESALIO Introduces NeVa NET 4.0 mm Following International Success of NeVa NET 5.5 mm Vesalio appoints CFO and announces company headquarters in Dallas, Texas Vesalio Announces Clinical Study Initiative for the Recently Launched pVasc Thrombectomy System and Planned Attendance at TCT, VIVA, and VEITH Meetings Uncontrolled Hypertension Could Bring Increased Risk For Alzheimer’s Disease Trauma-Induced Epilepsy May Be Prevented By Cooling The Brain Following Injury Thrombectomy technique choices The European Stroke Organisation (ESO) is delighted to be running the 9th ESO Conference (ESOC) 2023 on 24th – 26th May 2023 in Munich, Germany The European Society of Minimally Invasive Neurological Therapy (ESMINT) and the European Society of Neuroradiology (ESNR) sign a Memorandum of Understanding The Angels Initiative at ESOC 2021 The Alzheimer Europe Magazine: Dementia in Europe issue 33 published as an e-magazine The 5th annual European Stroke Organisation Conference (ESOC) – Media Releases Study Identifies Predictors Of Cognitive Impairment In Schizophrenia Stroke Action Plan for Europe (SAP-E) Implementing together Stroke Care in Europe Second day of virtual Alzheimer Europe Conference “Dementia in a changing world” focuses on diagnosis and medical management and on dementia–inclusive societies SEASON 2 EPISODE 1 OUT NOW: Reflections on Parkinson’s Disease Podcast by Professor Bas Bloem and Professor Werner Poewe SAFE Launches A Website For Stroke Prevention Registrations are open for the 33rd Alzheimer Europe Conference #33AEC! Prof. Thorsten Steiner joins Oruen Advisory Board Prof. Teus van Laar joins Oruen Advisory Board Prof. Simona Sacco joins Oruen Advisory Board Prof. Paolo Machi joins Oruen Advisory Board Prof. Olivier Rascol joins Oruen Advisory Board Prof. Nadia Hammami joins Oruen Advisory Board Prof. Markus Möhlenbruch joins Oruen Advisory Board Prof. Joaquim Ferreira joins Oruen Advisory Board Prof. Jens Fiehler joins Oruen Advisory Board Prof. Franziska Dorn joins Oruen Advisory Board Prof. Christophe Cognard joins Oruen Advisory Board People over the world talk about their Parkinson’s – Chapter 1 Parkinson’s Europe: The benefits of engaging with patient organisations like us! Parkinson’s cases will double to 25 million by 2050, BMJ study says Parkinson’s Life podcast: a voice for the global Parkinson’s community. LISTEN TO THE NEW EPISODE 5 Oruen The CNS Journal – Volume 5 Issue 1 (July 2019) Current Issue NOW PUBLISHED Oruen The CNS Journal – Volume 4 Issue 2 (December 2018) Current Issue Oruen The CNS Journal – Volume 4 Issue 1 Oruen Testimonial by Professor Werner Poewe NHS England releases new resources on intercultural dementia care including a joint guide with Alzheimer Europe New Alzheimer Europe report identifies key recommendations on legal capacity and decision making of people with dementia NeVa CLEAR Study results presented at ESMINT: innovative thrombectomy device achieves notable first-pass success and patient outcomes MULTIPLE SCLEROSIS (MS): EUROPEAN CONFERENCE CALLS FOR INCREASED FOCUS ON PROGRESSIVE MS MULTIPLE SCLEROSIS (MS): EUROPEAN CONFERENCE CALLS FOR INCREASED FOCUS ON PROGRESSIVE MS Medtronic Receives CE Mark Approval for Radial Artery Access Portfolio Life after stroke – what is the problem? Kids Get MS, too – National MS Society Interview With WSO President: Prof. Michael Brainin Interview With MDS President: Prof. Claudia Trenkwalder Interview with EMSP President: Prof. Pedro Carrascal Interview with ECNP President: Prof. Gitte Moos Knudsen Interested in the EANS Training Courses? Apply now for the 2021 entry! Hot Topics in Obstructive Sleep Apnea – A European View Highlights from the 34th Alzheimer Europe Conference Highlights from the 33rd Alzheimer Europe Conference Full costs of stroke in 32 European countries is €60 billion Final day of Alzheimer Europe’s first ever virtual conference focuses on moving from research and innovation to clinical and care practice, and on dementia as a European priority Exclusive Interview With ESO President: Prof. Martin Dichgans European WAKE-UP trial shows benefit of thrombolysis in stroke with unknown time of onset ESRS Celebrates certification of more than 1100 Somnologists and Somnologist Technologists ESOC 2021: Shaping the future ESO And SAFE Kick-Off The Implementation Of The Stroke Action Plan For Europe (SAP-E) – A Major Initiative To Reduce The Burden Of Stroke In Europe ESO & S.A.F.E – Declaration for Action on Stroke launches on European Stroke Awareness Day ESO / SAFE Press Release: Ukraine signs the Stroke Action Plan for Europe Declaration ESMINT PRESS RELEASE: Prof Dr Christian Taschner appointed to the European Commission’s Medical Devices Expert Panel ESMINT 11th Congress Impact Report 2019 EPND: New European initiative will build a collaborative platform for data and sample sharing, to accelerate the discovery and validation of biomarkers for neurodegenerative diseases EPDA survey on drooling (sialorrhea) in Parkinson’s eEANS2021 Virtual Congress: 3rd October – 7th October 2021 Educating And Enhancing The Role Of Belgian MS Nurses EANS2022 Abstract Submission is now open! EANS 2024 Sofia Congress – A Milestone in European Neurosurgery EANS 2023 Barcelona Congress: A Resounding Success! EANS 2022 Belgrade Congress: An event to remember! EANS 2020: The 20th European Congress of Neurosurgery goes virtual – Register Here! e-Journal Vol 7 Issue 2 (Jan 2022) Out Now! e-Journal Vol 7 Issue 1 (Aug 2021) Out Now! e-Journal Vol 6 (Jan 2021) Out Now! During greatest public health crisis in living memory, European Commission adopts first Work Plan of new EU4Health Programme undermining key activities of European health NGOs Dr. Serdar Geyik joins Oruen Advisory Board Dr. Paul Bhogal joins Oruen Advisory Board Dr. Mohamed Aggour joins Oruen Advisory Board Dr. Margherita Fabbri joins Oruen Advisory Board Dr Sanjeev Nayak joins Oruen Advisory Board Dr Markus Holtmannspötter joins Oruen Advisory Board Dr Gustavo Saposnik joins Oruen Advisory Board Deep Brain Stimulation Might Help Early In Parkinson’s An update on innovative stroke treatment An insight into the upcoming ESMINT Annual Meeting – Nice, France 2022 Alzheimer Europe supports the rights and dignity of people with dementia with three new publications, looking at employment and social protection, at sex, gender and sexuality and at ethical communication Alzheimer Europe sets out recommendations to improve data sharing in dementia research Alzheimer Europe rings the alarm about discriminatory practices in intensive care settings during the COVID-19 pandemic Alzheimer Europe regrets that negative European Medicines Agency opinion on lecanemab may deprive Europeans with Alzheimer’s disease from medicines available in the US and elsewhere Alzheimer Europe publishes two new reports: One on sex, gender and sexuality in the context of dementia, and one on dementia-inclusive initiatives and communities Alzheimer Europe Press release: Alzheimer Europe report outlines challenges associated with legal capacity and dementia Alzheimer Europe position regarding the prioritisation of people with dementia for COVID-19 vaccination Alzheimer Europe outlines state-of-play of dementia policy in Europe Alzheimer Europe lunch debate focuses on dealing with behavioural and psychological symptoms (BPSD) in dementia care Alzheimer Europe calls for urgent action to address the impact of COVID-19 on dementia research Alzheimer Europe calls for dementia to be a priority for European decision-makers Alzheimer Europe Board adopts recommendations on how to promote the wellbeing of people with dementia and carers during the COVID-19 pandemic Always a good time to learn about stroke prevention A Very Warm Welcome To Our New Advisory Board Member – Prof. George Ntaios A Very Warm Welcome To Our New Advisory Board Member – Peter Wolf A very warm welcome to our new advisory board member – Wolfgang Reith A very warm welcome to our new advisory board member – Prof. Mario Martínez-Galdámez A very warm welcome to our new advisory board member – Krassen Nedeltchev A Very Warm Welcome To Our New Advisory Board Member – Hans-Christoph Diener A Very Warm Welcome To Our New Advisory Board Member – Graeme Hankey A Very Warm Welcome To Our New Advisory Board Member – Angelo Antonini A Very warm welcome to our latest addition to the Advisory Board A very warm welcome to our latest addition to the Advisory Board A Very Warm Welcome To Our Latest Addition To The Advisory Board A very warm welcome to our latest addition to the Advisory Board A Very Warm Welcome To Our Latest Addition To The Advisory Board A Very Warm Welcome To Our Latest Addition To The Advisory Board A Very Warm Welcome To Our Latest Addition To The Advisory Board A testimonial from the ESO past president – Valeria Caso A successful collaboration between SAFE and the ANGELS Initiative helps improving patient – doctor communication 33rd Alzheimer Europe Conference agenda available online and new bursaries also available for early stage researchers! 30th Alzheimer Europe Virtual Conference “Dementia in a changing world” brings together almost 800 participants from 42 countries 30th Alzheimer Europe Conference #30AEC goes virtual! 17-19 October: 32nd Alzheimer Europe Conference takes place in Bucharest and online under the banner “Building bridges”, bringing together 544 participants from 42 countries “Resilience in dementia: Moving beyond the COVID-19 pandemic” brings together over 600 participants from 38 countries World Parkinson’s Day: New strategies and hope for the future – Improving quality of life for patients with Parkinson’s disease – Prof. Bas Bloem, Prof. Claudia Trenkwalder & Prof. Angelo Antonini What’s New In Parkinson’s Rating Scales? What to do when the honeymoon wears off What Parkinson’s Feels Like: artist with Parkinson’s releases new illustrated book What Is My Pd Journey? Weight Lifting Improves Physical Function in Parkinson’s Voice Disturbance Analysis Detects Parkinson’s Using The Apomorphine Sublingual Film In Practice: A Conversation Between Two Experts – Prof. Stuart Isaacson & Dr Eric Freire Treatment Options For Atypical Parkin-Sonisms Treating motor fluctuations in Parkinson‘s Disease – Prof. Tobias Warnecke The role of on-demand medications in Parkinson’s Disease – Prof. Joaquim Ferreira, Prof. Angelo Antonini & Dr Susan Fox The Role Of Apomorphine In The Effective Management Of Parkinson’S Disease – Highlights From Cony 2014 The Next Frontier for Parkinson’s disease and Movement Disorders: The Middle East, North Africa and South Asia (MENASA) region The impact of COVID-19 for families with Parkinson’s Disease The honeymoon’s over: what next for people with Parkinson’s? The efficacy of Apomorphine – A non-motor perspective: Prof. K Ray Chaudhuri The Diagnosis of Parkinson’s Disease – Dr. Francesca Morgante The Clinical Validation Of Objective Measurement Of Movement In Parkinson’s Disease Tailoring Levodopa according to patient characteristics Tai Chi Improved Postural Stability in Parkinson’s Disease Symptom Triad May Identify Parkinson’s Risk Study Hints at Statins’ Protective Effect Against Parkinson’s Roundtable discussion, Professors Werner Poewe, Angelo Antonini and Oliver Rascol discuss: “Is Delaying Levodopa a Disservice to Patients?” Rotigotine Patch Has Favorable Results in Parkinson’s, Restless Legs Role, Function and Effect of Catechol-O-Methyl Transferase In Humans And Parkinson Disease Risk Factors Identified for Impulse Control Disorders in Parkinson’s Reflections on Parkinson’s Disease Podcast – S2 EP4: ABC of PD – The Letter G: GBA and Genetics Reflections on Parkinson’s Disease Podcast – S2 EP3: ABC of PD – The Letter F: Fluctuations & Fatigue Reflections on Parkinson’s Disease Podcast – S2 EP2: ABC of PD – The Letter E: Early Morning Off, Evidence, Exercise, Early PD Reflections on Parkinson’s Disease Podcast – S2 EP1: ABC of PD – The Letter C: COMT Inhibitors, Continuous Dopaminergic Delivery Reflections on Parkinson’s Disease Podcast – EP7: Apomorphine and non-motor symptoms Reflections on Parkinson’s Disease Podcast – EP6: Talking PD – Issues in doctor-patient communication Reflections on Parkinson’s Disease Podcast – EP5: The Hardships Of Being Off Reflections on Parkinson’s Disease Podcast – EP4: Response Fluctuations in Parkinson’s Disease and why they can be missed Reflections on Parkinson’s Disease Podcast – EP3: Why PD patients start to fluctuate Reflections on Parkinson’s Disease Podcast – S2 EP7: ABC of PD – The Letter N (Part 2): Non Motor Symptoms – Apomorphine Reflections on Parkinson’s Disease Podcast – S2 EP5: ABC of PD – The Letter O: ON/OFF, On Demand Therapies, Opicapone Reflections on Parkinson’s Disease Podcast – EP2: Motor Fluctuations and the levodopa long-duration response Reflections on Parkinson’s Disease Podcast – EP1: Levodopa Facts and Myths Recognition and Management of Wearing Off Utilisation of Catechol-O-Methyltransferase (COMT) Inhibitors – Olivier Rascol Prof. David Devos, MD, PhD Expert opinion on early start of infusion therapies in PD (interview during MDS Congress, Nice, France, 24.09.2019) Prof. Angelo Antonini, MD, PhD – MDS Congress Madrid 2022 Predictive Analysis in Neurodegenerative Disease Progression Plotting A Better Pathway For Parkinson’s Disease: The My PD Journey Project Physiotherapy Found to Have Short-Term Benefit in Parkinson’s Pharmacodynamics of levodopa in the pathophysiology of fluctuations in Parkinson’s disease – Prof. Fabrizio Stocchi People over the world talk about their Parkinson’s – Chapter 1 Parkinson’s Life – A new ‘Webzine’ For The International Parkinson’s Community Now Live! Parkinson’s Europe: The benefits of engaging with patient organisations like us! Parkinson’s Life podcast: a voice for the global Parkinson’s community. LISTEN TO THE NEW EPISODE 5 Parkinson’s Disease: An update on basic concepts – Dr Monica Kurtis Parkinson’s Disease – Patient Roleplay Oruen Testimonial by Professor Werner Poewe Oruen Testimonial by Dr. Monica Kurtis Ocular Tremor a Possible Biomarker for Early Parkinson’s Disease Nonmotor Symptoms In Parkinson’s Disease Recognition & Management Nocturnal Sleep Boosts Working Memory Training in Parkinson’s New Developments In Parkinson’s Disease Management: Interviews With The Experts New Developments In Parkinson’s Disease Management: Interviews With The Experts Neuromelanin MR Imaging In Parkinson’s Disease Natural Toxins: Their Roles In Developing PD Multidisciplinary care in PD – Does it make a difference? Modulation of Levodopa Metabolism, The Role of COMT Inhibition and Opicapone ▼ Pharmacologic Profile MCI in Parkinson’s Linked to Frontostriatal Dysfunction Management of Parkinson’s Disease: From Science to Clinical Wisdom, Prof. Werner Poewe, Prof. Fabrizio Stocchi, Prof. Georg Ebersbach & Dr. Francesca Morgante Levodopa Mythology – Dr Alberto Espay Involving PD patients in their treatment management: Expert discussion: Prof Bas Bloem & Dr Margherita Fabbri Introduction To The Symposium How are we really optimising levodopa? The role of enzymatic inhibition Family History Tops Parkinson’s Disease Risk Factors Exercise Improved Some Cognitive Function in Parkinson’s EPDA #UniteForParkinsons Effect of vibrotactile stimulation with cueing on falls in Parkinson’s disease: case study Early vs Late Use Of Levodopa – Angelo Antonini Early use of Levodopa vs Levodopa-sparing strategies Drug For Alzheimer’s, Parkinson’s And MS Shows Promise Drug Dosage, Gender Affect Impulsivity Prognosis in Parkinson’s Disparities Seen in Care of Parkinson’s Patients : Better clinical care associated with neurologists was often unavailable to women or minorities. Diagnosis and Management of Wearing Off – Repositioning COMTi and Response Duration in Levodopa Optimisation Diagnosis and Management of Levodopa Response Fluctuations in Parkinson’s Disease Delayed ON And Wearing OFF – Complications Critical Case Considerations Continuous Dopaminergic Stimulation – Dr. Stuart Isaacson Coming Up Next: Managing Motor Complications In Parkinson’s Disease Clinical Manifestations, Pathophysiology and Impact of Motor Fluctuations in Patients Clinical Data of Opicapone ▼ for the Management of Motor Fluctuations in PD Patients Charco Neurotech – CUE1: Prof. James Kilner Changing the paradigm for treating motor fluctuations in Parkinson’s: advancements in COMT inhibition Botulinum Neurotoxin And Dystonia: A Case For Greater Flexibility In Treatment Regimens? Big Data Analytics for Predictive Modelling in Parkinson’s Disease An update of opicapone in Parkinson’s disease: evidence-based results of recent trials An Introduction to the Pharmacokinetics of Levodopa – Prof. Fabrizio Stocchi Am Impakt: Apomorphine For Morning Akinesia Trial – Results A2A Receptor Antagonists: Potential adjuvant therapies for levodopa optimisation “I am Cheryl”.. Quality Of Life Perspectives From A Patient With Cervical Dystonia “I am David”.. Quality Of Life Perspectives From A Patient With Cervical Dystonia ‘Wearing off’ to L-DOPA and its underlying mechanisms X Surface Treatment: The Latest Advancement in Flow Diversion Technology World Stroke Day 2024 – Stroke Management at the University Hospital Bonn, Germany WallabyPhenox – World Stroke Day 2024 VESALIO Introduces NeVa NET 4.0 mm Following International Success of NeVa NET 5.5 mm Vesalio appoints CFO and announces company headquarters in Dallas, Texas Updates from Industry Satellite Symposium, 16th May 2024, in Basel, Switzerland: 10th European Stroke Organisation Conference (ESOC) Updates from Industry and New Technology Symposia, Friday 9th September, 2022 in Nice, France: 14th Congress of the European Society of Minimally Invasive Neurological Therapy (ESMINT) Transforming the stroke care continuum together Transforming stroke care continuum together. A symposium supported and organised by Medtronic, ESO-WSO Virtual Congress 2020 Thrombectomy technique choices Three Part Round Table Discussion: Which Techniques To Achieve FPE? Experts Share Their Daily Practice The impact of COVID-19 on Hemorrhagic Procedures The Evolving Endovascular Therapy Toolkit: Real-World and Clinical Experiences with Pipeline Flex and Vantage with Shield Technology and Solitaire X 3 mm The changing world of innovative stroke treatment Stryker ESMINT 2023 – Prof. Dr. Markus Möhlenbruch Selecting patients for endovascular therapy and recent developments and clinical experience with Medtronic devices REDEFINING FLOW DIVERSION WITH PIPELINE™ FLEX WITH SHIELD™ TECHNOLOGY: RELEASE OF NEW CLINICAL DATA Prof. Dr. István Szikora – Press conference in October on the national stroke imaging network pRESET Testimonial: Dr Sanjeev Nayak – WallabyPhenox MicroVention-Terumo symposiums from ESMINT 2022, Nice, France Medtronic Receives CE Mark Approval for Radial Artery Access Portfolio Medtronic ESMINT TV Industry Slots – Featuring: Dr Leonardo Renieri, Dr Aiden Hegarty, Dr Alejandro Tomasello, Prof. Jens Fiehler & Dr Saleh Lamin Medtronic ESMINT TV Industry Slot: INSPIRE – S: Dr Pasquale Mordasini & Dr Marc Ribo Medtronic – Webinar Session: AVM Treatment Medtronic – Webinar Session: Aneurysm Treatment – Flow Diversion Complex Cases Medtronic – The Importance of Thrombectomy Medtronic – ESMINT 2021: Speaker: Professor René Chapot – Double Stent Retrievers (German) Medtronic – ESMINT 2021: Speaker: Professor René Chapot – Double Stent Retrievers (English) Medtronic – Acute Ischemic Stroke Launch Symposium Latest update on SESAME, SOFIA EPI & ERIC for distal Interview with the President of the ESMINT 2022 Annual Meeting – Dr Mohamed Aggour Innovations Driven By Clinical Evidence Ideas and Innovations in Acute Ischaemic Stroke Treatment ESOC 2019 – MEDTRONIC CARE CONTINUUM: Improving Patient Pathway ESO Endorsed Medtronic Webinar: AF screening in Cryptogenic Stroke patients, from guidelines to daily practice – 26th January 2023 ESMINT TV Studios 2024 ESMINT TV 2024 – Industry Session: Stronger Together: What’s next with WallabyPhenox – Speakers: Jens Fiehler & Markus Holtmannspötter ESMINT PRESS RELEASE: Prof Dr Christian Taschner appointed to the European Commission’s Medical Devices Expert Panel Empowering Women in INR: The WIN Group’s Latest Initiative Dr Don Frei shares insights about REDglide Difference & discusses ADAPT Technology with Joan Kristensen Clinical Advantages of NAEOTOM Alpha and ARTIS icono for Neurovascular Disease Celebrating 5 years commercialisation in Europe with Vesalio during ESMINT 2023! An update on innovative stroke treatment An insight into the upcoming ESMINT Annual Meeting – Nice, France 2022 Advancing Aneurysm Treatment with ARTIS icono 3D imaging and the combination of Sim&Cure Device Simulation 1-2-1 interviews on WEB Study – Dr. Szikora, Dr. Arthur, Prof. Pierot & Propriety X Surface Treatment for Flow Diverter -Dr. Dion World Stroke Day 2024 – Stroke Management at the University Hospital Bonn, Germany What is the future for NOACs in secondary prevention of ESUS? – Christina Sjöstrand, Hans-Christoph Diener & George Ntaios WallabyPhenox – World Stroke Day 2024 Vesalio Announces Clinical Study Initiative for the Recently Launched pVasc Thrombectomy System and Planned Attendance at TCT, VIVA, and VEITH Meetings Updates from Industry Satellite Symposium, 16th May 2024, in Basel, Switzerland: 10th European Stroke Organisation Conference (ESOC) Transforming the stroke care continuum together Three Part Round Table Discussion: Which Techniques To Achieve FPE? Experts Share Their Daily Practice Protected: The Novel Oral Anticoagulants For Af…What Do The Sub-Analyses Tell Us? The Impact Of Thrombectomy For Stroke Patients In the UK – World Stroke Day 29th October 2022 The impact of COVID-19 on Hemorrhagic Procedures The changing world of innovative stroke treatment The Angels Initiative: Stroke care taking flight with the wings of Angels – ESO-WSO Virtual Congress 2020 The Angels Initiative at ESOC 2021 The Angels (Acute-Networks StrivinG For ExceLlence In Stroke) Initiative: Solving A Problem By Giving Physicians The Tools They Need To Create A Solution Tenecteplase Edges TPA in Acute Stroke Stryker ESMINT 2023 – Prof. Dr. Markus Möhlenbruch Strokes Mix Up Brain And Muscle Coordination Stroke Treatment From Onset To Rehabilitation Stroke Severity Is Key in Hospital Rankings for Stroke Outcomes Stroke Prevention in AF: Study Finds Some Differences Among New OACs Stroke care taking flight with the wings of ANGELS Stroke Association Reviewing Stroke Definition, New Anticoagulants Some Recommendations To Address The Burden Of Stroke In Europe Solitaire Trumped Merci in Stroke Clot Retrieval Trial Solitaire Clot Remover Effective for Large Artery Stroke Significant Risk Factors In The Etiology Of Arterial Ischemic Stroke In Children Secondary Stroke Prevention: Who Can Benefit from Device Therapies? Scores Help Identify Stroke Patients at Risk of Brain Bleed Roundtable Discussion – Brain, Heart and Kidneys: Preserving the Balance in Stroke Prevention Role of Patent Foramen Ovale Varies in Cryptogenic Strokes Robots May Extend Post-Stroke Race REDEFINING FLOW DIVERSION WITH PIPELINE™ FLEX WITH SHIELD™ TECHNOLOGY: RELEASE OF NEW CLINICAL DATA RE-SPECT ESUS: Optimizing Prevention of Embolic Stroke of Undetermined Source – Mike Sharma, Richard A. Bernstein & Hans-Christoph Diener RE-SPECT ESUS: Dabigatran versus acetylsalicylic acid for stroke prevention in patients with embolic stroke of undetermined source – Hans-Christoph Diener Prof. Dr. István Szikora – Press conference in October on the national stroke imaging network Pretreatment ASPECTS Reading Affects Stroke Outcomes pRESET Testimonial: Dr Sanjeev Nayak – WallabyPhenox Pilot Program Shows Cardiac Rehab Can Help Poststroke Patients’ testimonials, Stroke Management in Tunisia Past And Future Of Stroke Care In Europe – How Can Sits Support? Past & Future Of Stroke Care In Europe Oral Relaxin Improves Poststroke Recovery Novel Stroke Prophylaxis Strategies: When Should Device-Based Cardiac Occlusion Therapies Be Considered? NOACs in Secondary Stroke Prevention – Robin Lemmens, Ales Tomek & Milan R. Voško New Stroke Outcome Data – Prolonged Cardiac Monitoring Prevents Secondary Strokes – Valeria Caso, Helmut Pürerfellner & Georgios Tsivgoulis Minimizing The Risk Of Hemorrhagic Stroke During Oral Anticoagulant Therapy For Atrial Fibrillation: The Neurologist’s Perspective Minimizing The Risk Of Haemorrhagic Stroke During Oral Anticoagulant Therapy For Atrial Fibrillation: The Neurologists’ Perspectives Meta-Analysis: Statins Don’t Prevent Stroke, Death in Women Mental Training For Reinstallation Of Motor Programs After Stroke – Fiction Or Science? Memory Declines Years Before Stroke Strikes Meet The Expert Session: A case-based debate: which of your patients might benefit from left atrial appendage occlusion? Medtronic ESMINT TV Industry Slots – Featuring: Dr Leonardo Renieri, Dr Aiden Hegarty, Dr Alejandro Tomasello, Prof. Jens Fiehler & Dr Saleh Lamin Medtronic ESMINT TV Industry Slot: INSPIRE – S: Dr Pasquale Mordasini & Dr Marc Ribo Medtronic – ESMINT 2021: Speaker: Professor René Chapot – Double Stent Retrievers (German) Medtronic – ESMINT 2021: Speaker: Professor René Chapot – Double Stent Retrievers (English) Mechanical Thrombectomy, The Change Is Coming. Mechanical Embolectomy Device Cleared for Acute Stroke Treatment Measurement And Improvement Of Stroke Care, Eso-East Maternal Hypertension Ups Infant’s Stroke Risk Life after stroke – what is the problem? Leaving A Legacy Of Stroke In Europe: A Community Of Dedicated Professionals Is Changing The Face Of Stroke In Europe Learnings from the ESUS trials – Jesse Dawson, Martin Grond & Maurizio Paciaroni Latest update on SESAME, SOFIA EPI & ERIC for distal Interview With WSO President: Prof. Michael Brainin Innovations Driven By Clinical Evidence Infection Correlated With Stroke Risk in Children In-Hospital Management Of Acute Ischaemic Stroke: How Can We Do Better? Implementation of Best Practice in Europe: The Angels Initiative – The Role Of ESO Hormonal Contraception Raises Thrombotic Stroke, MI Risk High-Tech Stroke Recovery Aids? More Likely Than You May Think Protected: From Studies To Real-Life Evidence…Latest Insights From The Garfield Af Registry Framingham Score Flags MI Risk After Stroke Filgrastim Fails to Improve Ischemic Stroke Outcomes Exclusive Interview With ESO President: Prof. Martin Dichgans Establishing stroke systems of care from the bottom to the top: A global perspective ESOC TV 2023 – Industry Slot: Astra Zeneca – Managing Bleeds in the Anticoagulated Patient; protocol and pathways ESOC 2023 TV – Industry Slot: Siemens – Advanced Imaging Techniques for Stroke Assessment and Prevention ESOC 2023 TV – Industry Slot: Neurologica Corp Samsung – The Benefits and Challenges of Setting Up a Mobile Stroke Program ESOC 2023 TV – Industry Slot: MicroVention – SOFIA™ Catheter 10th anniversary celebration – ETIS registry : ERIC™ Stent Retriever & SOFIA™ Catheter clinical data ESOC 2023 TV – Industry Slot: Apoplex – Rapid AF detection by automated continuous ECG monitoring using Stroke-Risk-Analysis (SRA®) ESOC 2021: Shaping the future ESOC 2019 – MEDTRONIC CARE CONTINUUM: Improving Patient Pathway ESOC 2017 Conference News ESOC 2017 – Day 2 Highlights ESOC 2017 – Day 1 Highlights ESO Endorsed Medtronic Webinar: Cryptogenic Stroke Patients Need Answers: AF Screening Strategies & Patient Stratification ESO & S.A.F.E – Declaration for Action on Stroke launches on European Stroke Awareness Day ESO / SAFE Press Release: Ukraine signs the Stroke Action Plan for Europe Declaration ESMINT TV Studios 2024 ESMINT TV 2024 – Industry Session: Stronger Together: What’s next with WallabyPhenox – Speakers: Jens Fiehler & Markus Holtmannspötter ESC 2014. In-Hospital Management Of Acute Ischaemic Stroke: How Can We Do Better? Epilepsy Incidence High Following Pediatric Stroke Embolic Stroke of Undetermined Source (ESUS) – Valeria Caso, Danilo Toni & Martin Grond Elderly Stroke Patients Have High Atrial Fibrillation Prevalence Depressed Stroke Survivors At Increased Risk Of Death CT Perfusion in Acute Stroke Questioned Cryptogenic Stroke Webinar – ESO-WSO Virtual Congress 2020 Clot-Busters Safely Treated Wake-Up Stroke Patients Clinical Advantages of NAEOTOM Alpha and ARTIS icono for Neurovascular Disease Brainomix Symposium – ESOC 2023 – Prof. Joan Montaner, Dr Kiruba Nagaratnam, Dr Manu Moreu & Dr Alex Szolics Boehringer Ingelheim: WSC 2018 – secondary stroke prevention: new evidence that demands a verdict Boehringer Ingelheim: ESOC 2019 – How NOAC selection and reversal can help protect our patients: Your questions answered Boehringer Ingelheim: Angels WSC 2018 – Improving Stroke Care Across The World: The Angels Initiative Boehringer Ingelheim: Angels ESOC 2019 – THE ANGELS INITIATIVE: 3 YEARS AND COUNTING Boehringer Ingelheim: Actilyse WSC 2018 – New Frontiers in Acute Ischaemic Stroke Reperfusion Boehringer Ingelheim ESOC 2018 – Stroke Prevention and Treatment: New Insights Into NOACS and Reversal Bayer: ESOC 2019 – Brain, Heart and Kidneys: Preserving the Balance in Stroke Prevention Atrial Fibrailation In Young Stroke Patients Anticoagulation for Cerebral Venous Thrombosis Anticoagulant Reversal Strategies in ICH – Current challenges and latest insights Protected: Anti-Coagulation With Novel Oac’s In Af, Practical Guidance And Interactive Session Angels: FAST Heroes: Results of cross-country implementation of a global school-based stroke education campaign – ESOC 2022 Studios Angels ESOC 2018 – Experience From Today For The Stroke Care Of The Future Anemia Triples Post-Stroke Mortality Risk An alternative treatment to prevent stroke in patients with Atrial Fibrillation: Left Atrial Appendage Occlusion-Latest evidence Alive or Dead? Secondary Stroke Prevention with NOACs in ESUS – Ken Butcher Air Pollution May Hurt Cognition, Increase Strokes Advancing Aneurysm Treatment with ARTIS icono 3D imaging and the combination of Sim&Cure Device Simulation Advanced Imaging To Extend The Therapeutic Time Window Of Acute Ischemic Stroke A testimonial from the ESO past president – Valeria Caso A message from the ESO President – Professor Valeria Caso ‘Drip and Ship’ Proves Safe for Stroke Vol. 6, Jan 2021 eJournal: Coming soon….. Transition of ADHD Patients from Childhood into Adulthood Transforming Stroke Care Through Advancements in Technology and an Overview of the PROSPR-SEA Post-Market Surveillance Study Three years of Angels: delivering a vision of consistent improvements in stroke care, internationally The Unrecognised Adult ADHD Patient: accidents, brain injury and behaviour The Stroke Care Continuum and Patient Pathway The impact of COVID-19 for families with Parkinson’s Disease The ANGELS Initiative: More and better Stroke-ready hospitals across the globe The ANGELS Initiative: Improving Stroke Care in Asia Symposium: Redefining Flow Diversion using Pipeline™ Flex with Shield Technology™ — Release of New Clinical Data Stroke prevention in atrial fibrillation: update with NOAC treatment and the impact of reversal Stroke Prevention and Treatment: New Insights into NOACs and Reversal Stroke experts produced a Stroke Action Plan for Europe (2018-2030) Stroke care taking flight with the wings of ANGELS Stroke Stroke State of the art on acute ischemic stroke: Systems of Care and In-hospital Organization State of the art on acute ischemic stroke: late breaking clinical trials Spanish: Using The Apomorphine Sublingual Film In Practice: A Conversation Between Two Experts – Prof. Stuart Isaacson & Dr Eric Freire Serum Epidermal Growth Factor Predicts Cognitive Functions In Early, Drug-Naive Parkinson’s Disease Patients Selecting patients for endovascular therapy and recent developments and clinical experience with Medtronic devices SAFE launches a website for stroke prevention SAFE Angels Project: Exciting new initiative gives stroke patients expert information Role, Function and Effect of Catechol-O-Methyl Transferase In Humans And Parkinson Disease Preserving the Balance in Stroke Prevention: Brain, Heart and Kidneys (symposium summary sponsored by Bayer) Patients and carers expertise important for the credibility of the European Stroke Action Plan Overall Self-Perceived Health In Restless Legs Treated With Intrathecal Morphine Oruen PD Patient Role Play Olfaction in migraine and its psychiatric comorbidities: a narrative review Moving Forward With Prisms: Sensory-Motor Adaptation Improves Gait Initiation In Parkinson’s Disease Modified Pediatrics ASPECTS Correlates With Infarct Volume In Childhood Arterial Ischemic Stroke Migraine | Migraine Relief Treatment Medtronic Symposium, ESOC 2017 – Leopold Saltuari Medtronic Symposium, ESOC 2017 – Krassen Nedeltchev Medtronic Symposium, ESOC 2017 – Jan Gralla Medtronic Symposium, ESOC 2017 – Antonio Davalos Medtronic Meet The Experts Session – Sergio Zimatore ESOC 2017 Medtronic Meet The Experts Session – Raffaele Augelli ESOC 2017 Medtronic Meet The Experts – Carlos A. Molina ESOC 2017 Looking for the ‘I’, ‘Me’ and ‘Other’ in Patient Stories Insights from ESOC: Improving Patient Pathways in Stroke Innovations in Endovascular Treatment of Acute Ischemic Stroke and Cerebral Aneurysms Individualized therapeutic levels: Adequate use of antiepileptic drug monitoring Improving stroke care across the world: the Angels Initiative Ideas and Innovations in Acute Ischaemic Stroke Treatment How NOAC Selection and Reversal Can Help Protect Our Patients: Your Questions Answered Functional somatic symptoms and syndromes in children and young people – a psychiatric perspective Full costs of stroke in 32 European countries is €60 billion Experience from Today for the Stroke Care of the Future European WAKE-UP trial shows benefit of thrombolysis in stroke with unknown time of onset ESMINT partners in EU funded research project: Clinical study starts in eight European countries Episode 4 Out Now – Reflections on Parkinson’s Disease Podcast by Professor Bas Bloem and Professor Werner Poewe Epilepsy research: MRI | NHS Epilepsy Drug Can Reverse Memory Loss In Alzheimer’s Patients Empowering stroke advocates through e-learning: SSOFT Embolic Stroke of Undetermined Source (ESUS) EANS 2023 Barcelona Congress: A Resounding Success! Dissection method affects electrophysiological properties of hippocampal slices Deep Brain Stimulation – Effects On Swallowing Function In Parkinson’s Disease Cognitive Rehabilitation In Parkinson’s Disease: Evidence From Neuroimaging Clinical Outcomes and Work Flow Optimisation with Pipeline System and Shield Technology Boehringer Ingelheim: Angels ESOC 2019 – THE ANGELS INITIATIVE: 3 YEARS AND COUNTING Bipolar UK’s response to medication shortages An introduction to the Internal Capsule in schizophrenia An introduction to the Globus Pallidus in schizophrenia An alternative treatment to prevent stroke in patients with Atrial Fibrillation: Left Atrial Appendage Occlusion – Latest evidence and discussion (2 part webinar) Always a good time to learn about stroke prevention Acute Nicotine Treatment Attenuates Learning and Memory Impairment in REM Sleep Deprivation through Modulation of CREB and BDNF Protein Expression in Rat’s Hippocampus A successful collaboration between SAFE and the ANGELS Initiative helps improving patient – doctor communication
We use cookies to ensure that we give you the best experience on our website, please read our Privacy Policy before using this website. I consent Privacy policy 
